应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BBC Virtus LifeSci Biotech Clinical Trials ETF
盘前交易 11-19 07:08:42 EST
39.77
-0.40
-1.00%
最高
41.14
最低
39.76
成交量
2.91万
今开
40.50
昨收
40.17
日振幅
3.44%
总市值
3,182万
流通市值
3,182万
总股本
80.00万
成交额
116.78万
换手率
3.63%
流通股本
80.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
研究员:Zoom、BBC 和 Ledger 等网站受恶意脚本攻击
链捕手 · 11-17 07:42
研究员:Zoom、BBC 和 Ledger 等网站受恶意脚本攻击
悦康药业:子公司YKYY018雾化吸入剂获FDA临床试验批准
智通财经 · 11-12
悦康药业:子公司YKYY018雾化吸入剂获FDA临床试验批准
翰宇药业(300199.SZ):HY3003注射液获得美国FDA临床试验许可
智通财经 · 11-04
翰宇药业(300199.SZ):HY3003注射液获得美国FDA临床试验许可
翰宇药业:HY3003注射液获美国FDA临床试验许可
智通财经 · 11-04
翰宇药业:HY3003注射液获美国FDA临床试验许可
葛兰素史克(GSK.US)、Inovio(INO.US)、Agios(AGIO.US)扎堆候审,美股创新药迎FDA审批窗口
智通财经 · 10-19
葛兰素史克(GSK.US)、Inovio(INO.US)、Agios(AGIO.US)扎堆候审,美股创新药迎FDA审批窗口
西藏药业(600211.SH):子公司ART002g1注射液获得美国FDA临床试验许可
智通财经 · 10-16
西藏药业(600211.SH):子公司ART002g1注射液获得美国FDA临床试验许可
西藏药业:控股子公司ART002g1注射液获美国FDA临床试验许可
智通财经 · 10-16
西藏药业:控股子公司ART002g1注射液获美国FDA临床试验许可
英国广播公司称,阿富汗当局已暂停BBC在阿富汗境内所有调频广播站点的信号传输。
智通财经 · 10-13
英国广播公司称,阿富汗当局已暂停BBC在阿富汗境内所有调频广播站点的信号传输。
华润双鹤:DC7001A胶囊获美国FDA临床试验许可
智通财经 · 10-11
华润双鹤:DC7001A胶囊获美国FDA临床试验许可
翰宇药业(300199.SZ):HY3003注射液获得美国FDA临床试验申请受理
智通财经 · 10-08
翰宇药业(300199.SZ):HY3003注射液获得美国FDA临床试验申请受理
一品红(300723.SZ)子公司创新药APH04935片获得美国FDA临床试验批准
智通财经 · 10-08
一品红(300723.SZ)子公司创新药APH04935片获得美国FDA临床试验批准
一品红:APH04935片获美国FDA临床试验批准
智通财经 · 10-08
一品红:APH04935片获美国FDA临床试验批准
乐普医疗:子公司MWN110注射液获美国FDA临床试验批准
智通财经 · 09-28
乐普医疗:子公司MWN110注射液获美国FDA临床试验批准
德展健康:WYY026B获美国FDA临床试验批准
智通财经 · 09-28
德展健康:WYY026B获美国FDA临床试验批准
凯莱英旗下公司入选上海市生物医药研发和检测用物品进口试点企业目录
智通财经 · 09-01
凯莱英旗下公司入选上海市生物医药研发和检测用物品进口试点企业目录
上海 市商务委等六部门和单位关于公布上海市生物医药研发和检测用物品进口试点企业目录的通知
智通财经 · 09-01
上海 市商务委等六部门和单位关于公布上海市生物医药研发和检测用物品进口试点企业目录的通知
据BBC,哈里王子、妻子梅根及其子女今日将返回英国。
格隆汇 · 08-26
据BBC,哈里王子、妻子梅根及其子女今日将返回英国。
全球平均海温创历史新高,“或是上一个间冰期以来最暖海温”
澎湃新闻 · 08-25
全球平均海温创历史新高,“或是上一个间冰期以来最暖海温”
舒泰神:子公司STSP-0601获美国FDA临床试验许可
智通财经 · 08-20
舒泰神:子公司STSP-0601获美国FDA临床试验许可
骏利亨德森投资:专利到期倒逼药企扩张 生物科技并购、IPO市场同步复苏
智通财经网 · 08-19
骏利亨德森投资:专利到期倒逼药企扩张 生物科技并购、IPO市场同步复苏
加载更多
公司概况
公司名称:
Virtus LifeSci Biotech Clinical Trials ETF
所属市场:
ARCA
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":39.77,"timestamp":1795035600000,"preClose":40.17,"halted":0,"volume":29062,"delay":0,"changeRate":-0.009957679860592447,"floatShares":800004,"shares":800004,"eps":0,"marketStatus":"盘前交易","change":-0.4,"latestTime":"11-19 07:08:42 EST","open":40.5,"high":41.14,"low":39.76,"amount":1167768,"amplitude":0.034354,"askPrice":47.44,"askSize":100,"bidPrice":15.99,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795098600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":39.77,"sharesOutstanding":900004,"nav":40.283,"aum":32226938.78,"dividendRate":0.0165,"bidAskSpread":0.002566,"postHourTrading":{"tag":"盘后","latestPrice":39.77,"preClose":39.77,"latestTime":"16:15 EST","volume":11,"amount":437.56,"timestamp":1795036500419,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9958332707639453,"impliedVol":0.4077,"impliedVolPercentile":0.948},"requestUrl":"/m/hq/s/BBC","defaultTab":"news","newsList":[{"id":"2684297346","title":"研究员:Zoom、BBC 和 Ledger 等网站受恶意脚本攻击","url":"https://stock-news.laohu8.com/highlight/detail?id=2684297346","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684297346?lang=zh_cn&edition=full","pubTime":"2026-11-17 07:42","pubTimestamp":1794872564,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,安全研究员披露,恶意脚本通过 Optimizely 影响 178 家机构,包括 Zoom、BBC、HSBC 和 Ledger。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2305366","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682650095","title":"悦康药业:子公司YKYY018雾化吸入剂获FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2682650095","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682650095?lang=zh_cn&edition=full","pubTime":"2026-11-12 17:22","pubTimestamp":1794475349,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680038292","title":"翰宇药业(300199.SZ):HY3003注射液获得美国FDA临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2680038292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680038292?lang=zh_cn&edition=full","pubTime":"2026-11-04 16:19","pubTimestamp":1793780377,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰宇药业 发布公告,公司于近日收到美国食品药品监督管理局下发的关于HY3003注射液的临床试验许可通知。FDA已完成对该IND申请的安全性审查,并同意公司按照提交的临床试验方案开展首次临床试验。该项目采用多剂型并行的开发策略,开发方向包括HY3003注射液(周制剂)、HY3003缓释注射液(月制剂)以及HY3003片剂。本次获得FDA临床试验许可的HY3003注射液为每周皮下注射给药一次。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","300199","BK0070","BK0188","BK0239","BK0028","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680389190","title":"翰宇药业:HY3003注射液获美国FDA临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2680389190","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680389190?lang=zh_cn&edition=full","pubTime":"2026-11-04 16:11","pubTimestamp":1793779885,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676475688","title":"葛兰素史克(GSK.US)、Inovio(INO.US)、Agios(AGIO.US)扎堆候审,美股创新药迎FDA审批窗口","url":"https://stock-news.laohu8.com/highlight/detail?id=2676475688","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676475688?lang=zh_cn&edition=full","pubTime":"2026-10-19 19:25","pubTimestamp":1792409117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","INO","BK4139","BK4583","IBBJ","BK4568","AGIO","BBP","RXL","IEIH","FBT","MEDX","BBC","PTH","LNGR","PILL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675567535","title":"西藏药业(600211.SH):子公司ART002g1注射液获得美国FDA临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2675567535","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675567535?lang=zh_cn&edition=full","pubTime":"2026-10-16 16:41","pubTimestamp":1792140110,"startTime":"0","endTime":"0","summary":"智通财经APP讯,西藏药业 发布公告,近日,公司控股子公司下属ACCUREDIT THERAPEUTICS US LIMITED收到美国食品药品监督管理局关于同意ART002g1注射液进行临床试验的通知。ART002g1注射液是以PCSK9为靶点的体内基因编辑药物, ART002g1在ART002的基础上进一步优化了mRNA和gRNA等组分。PCSK9靶点目前已有单克隆抗体、siRNA等作用机制的产品获批上市,体内基因编辑领域尚没有相关产品获批上市。截至本公告日,针对该药品累计研发投入为人民币6,603.16万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1508285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600211","BBC","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675156403","title":"西藏药业:控股子公司ART002g1注射液获美国FDA临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2675156403","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675156403?lang=zh_cn&edition=full","pubTime":"2026-10-16 16:09","pubTimestamp":1792138192,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675344523","title":"英国广播公司称,阿富汗当局已暂停BBC在阿富汗境内所有调频广播站点的信号传输。","url":"https://stock-news.laohu8.com/highlight/detail?id=2675344523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675344523?lang=zh_cn&edition=full","pubTime":"2026-10-13 16:37","pubTimestamp":1791880621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674143678","title":"华润双鹤:DC7001A胶囊获美国FDA临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2674143678","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674143678?lang=zh_cn&edition=full","pubTime":"2026-10-11 15:32","pubTimestamp":1791703920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673402225","title":"翰宇药业(300199.SZ):HY3003注射液获得美国FDA临床试验申请受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2673402225","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673402225?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:30","pubTimestamp":1791448240,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰宇药业(300199.SZ)发布公告,公司于近日收到美国食品药品监督管理局(FDA)下发的关于HY3003注射液的临床试验申请受理通知。HY3003系一款利用AI多肽芯片技术筛选出的GLP-1R/GIPR/GCGR三靶点受体激动剂,拟用于减重、2型糖尿病、代谢相关脂肪性肝炎等适应症,是公司在代谢疾病领域布局的重磅创新药品种。HY3003项目采用多剂型并行的开发策略,开发方向包括HY3003注射液(周制剂)、HY3003缓释注射液(月制剂)以及 HY3003片(每日一次的口服制剂)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300199","BK0070","BK0077","BBC","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673477770","title":"一品红(300723.SZ)子公司创新药APH04935片获得美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2673477770","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673477770?lang=zh_cn&edition=full","pubTime":"2026-10-08 11:52","pubTimestamp":1791431539,"startTime":"0","endTime":"0","summary":"智通财经APP讯,一品红(300723.SZ)发布公告,近日,公司全资子公司广州一品红制药有限公司(简称“一品红制药”)收到美国食品药品监督管理局(FDA)下发的关于同意公司子公司自主研发的创新药物APH04935片临床试验的函。APH04935 片是由公司自主研发的一种高活性、高选择性的小分子GLP-1R(全称:Glucagon-like Peptide-1 Receptor,中文译为:胰高血糖素样肽-1 受体)激动剂,目标成为一款一天给药一次的口服小分子 GLP-1R 激动剂,拟用于控制体重及长期减重管理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","BK0239","LNGR","BK1161","06978","IBBQ","MEDX","BBC","BK1574","300723"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673047785","title":"一品红:APH04935片获美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2673047785","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673047785?lang=zh_cn&edition=full","pubTime":"2026-10-08 11:44","pubTimestamp":1791431090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239318","title":"乐普医疗:子公司MWN110注射液获美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239318","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670239318?lang=zh_cn&edition=full","pubTime":"2026-09-28 18:40","pubTimestamp":1790592021,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670280131","title":"德展健康:WYY026B获美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670280131","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670280131?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:42","pubTimestamp":1790584921,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383627","title":"凯莱英旗下公司入选上海市生物医药研发和检测用物品进口试点企业目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664383627?lang=zh_cn&edition=full","pubTime":"2026-09-01 15:03","pubTimestamp":1788246222,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RND","XBIX","WRND","BBC","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664836502","title":"上海 市商务委等六部门和单位关于公布上海市生物医药研发和检测用物品进口试点企业目录的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2664836502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664836502?lang=zh_cn&edition=full","pubTime":"2026-09-01 14:44","pubTimestamp":1788245063,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC","IBBQ","RND","XBIX","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715370","title":"据BBC,哈里王子、妻子梅根及其子女今日将返回英国。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715370","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662715370?lang=zh_cn&edition=full","pubTime":"2026-08-26 19:27","pubTimestamp":1787743654,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662887427","title":"全球平均海温创历史新高,“或是上一个间冰期以来最暖海温”","url":"https://stock-news.laohu8.com/highlight/detail?id=2662887427","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662887427?lang=zh_cn&edition=full","pubTime":"2026-08-25 11:16","pubTimestamp":1787627760,"startTime":"0","endTime":"0","summary":"据多家外媒24日报道,欧盟哥白尼气候变化服务中心披露数据显示,全球非极地海域平均海面温度于8月22日达到21.1℃,刷新有记录以来的最高值。渥太华大学教授瑞安·卡茨-罗森在X上写道: “这甚至可能是12.5万年前的上一个间冰期以来最温暖的海面温度。”专家认为,在这一反常时段出现历史新高,凸显出全球海洋持续升温的严峻趋势。BBC报道称,英国及欧洲周边海域也持续出现异常高温。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-25/doc-inipnyqs9667453.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-25/doc-inipnyqs9667453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402884","title":"舒泰神:子公司STSP-0601获美国FDA临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402884","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660402884?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:22","pubTimestamp":1787214150,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"骏利亨德森投资:专利到期倒逼药企扩张 生物科技并购、IPO市场同步复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660431564?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称,尽管利率较市场年初的预期为高,但生物科技行业交易活动的增长动力持续不减。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4582","MRNY","FBT","BIS","BK4588","GTPE","BBC","BBP","PBE","JDOC","MRNX","IAI","SPCK","BK4585","IJT","IYG","QSML","BIB","IBB","IWO","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1202},{"period":"1month","weight":-0.0257},{"period":"3month","weight":-0.2618},{"period":"6month","weight":-0.0688},{"period":"1year","weight":0.1784},{"period":"ytd","weight":0.0314}],"compareEarnings":[{"period":"1week","weight":-0.039},{"period":"1month","weight":-0.0473},{"period":"3month","weight":-0.0425},{"period":"6month","weight":-0.0207},{"period":"1year","weight":0.1062},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.00559},{"month":2,"riseRate":0.583333,"avgChangeRate":0.010722},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.021111},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.006398},{"month":5,"riseRate":0.583333,"avgChangeRate":0.023096},{"month":6,"riseRate":0.666667,"avgChangeRate":0.036229},{"month":7,"riseRate":0.5,"avgChangeRate":0.013862},{"month":8,"riseRate":0.666667,"avgChangeRate":0.018731},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.018015},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.022071},{"month":11,"riseRate":0.666667,"avgChangeRate":0.06491},{"month":12,"riseRate":0.454545,"avgChangeRate":0.000413}],"exchange":"ARCA","name":"Virtus LifeSci Biotech Clinical Trials ETF","nameEN":"Virtus LifeSci Biotech Clinical Trials ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Virtus LifeSci Biotech Clinical Trials ETF(BBC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Clinical Trials ETF(BBC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Virtus LifeSci Biotech Clinical Trials ETF,BBC,Virtus LifeSci Biotech Clinical Trials ETF股票,Virtus LifeSci Biotech Clinical Trials ETF股票老虎,Virtus LifeSci Biotech Clinical Trials ETF股票老虎国际,Virtus LifeSci Biotech Clinical Trials ETF行情,Virtus LifeSci Biotech Clinical Trials ETF股票行情,Virtus LifeSci Biotech Clinical Trials ETF股价,Virtus LifeSci Biotech Clinical Trials ETF股市,Virtus LifeSci Biotech Clinical Trials ETF股票价格,Virtus LifeSci Biotech Clinical Trials ETF股票交易,Virtus LifeSci Biotech Clinical Trials ETF股票购买,Virtus LifeSci Biotech Clinical Trials ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Virtus LifeSci Biotech Clinical Trials ETF(BBC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Clinical Trials ETF(BBC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}